TrialBreast (Edinburgh, Scotland)2020

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).

Laura Orlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.